TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25608756

Group type: EXPERIMENTAL
Intervention: Prednisone 50 mg daily for 7 days
Number of subjects: 785

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 785
Study: 23504141

Group type: EXPERIMENTAL
Intervention: [(99m)Tc]tilmanocept
Number of subjects: 148

Group type: COMPARATOR
Intervention: VBD
Number of subjects: 148
Study: 22696891

Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.3 mg/kg/d + zinc sulfate 10 mg/d (GZN)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Methylphenidate 0.3 mg/kg/d + placebo (GPL)
Number of subjects: 40
Study: 19696423

Group type: EXPERIMENTAL
Intervention: Enoxaparin (40 mg once daily for 10 days)
Number of subjects: 1749

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) (5000 U every 12 hours for 10 days)
Number of subjects: 1749

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 1749

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 1749

Group type: EXPERIMENTAL
Intervention: Enoxaparin and UFH
Number of subjects: 1749
Study: 16714361

Group type: EXPERIMENTAL
Intervention: Leg crossing
Number of subjects: 9

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 9
Study: 15046215

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Open-label UDCA (after initial trial)
Number of subjects: 151
Study: 11371662

Group type: EXPERIMENTAL
Intervention: Trocade 25 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Trocade 50 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Trocade 100 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Trocade 150 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 9215232

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 460

Group type: COMPARATOR
Intervention: Placebo (for Simvastatin)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Placebo (for Enalapril)
Number of subjects: 460
Study: 8181128

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nitroprusside
Number of subjects: 36
Study: 3297678

Group type: EXPERIMENTAL
Intervention: 3 mg kg‐1 captopril pre‐treated patients
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control patients
Number of subjects: 12
Study: 29804892

Group type: EXPERIMENTAL
Intervention: Horticultural therapy (HT), 60-minute sessions for 8 weeks
Number of subjects: 111

Group type: COMPARATOR
Intervention: Social activities (control)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Horticultural therapy (HT)
Number of subjects: 111
Study: 27155586

Group type: EXPERIMENTAL
Intervention: Rivaroxaban mono-therapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard-therapy with enoxaparin followed by vitamin K antagonist (VKA)
Number of subjects: 62
Study: 25530057

Group type: EXPERIMENTAL
Intervention: Injection at a seeking current of 0.8 mA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Injection at a seeking current of <0.5 mA
Number of subjects: 60
Study: 24473591

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine - ma zi ren wan (MZRW) 7.5 g bid
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 20166795

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2533
Study: 17634383

Group type: EXPERIMENTAL
Intervention: Walking program
Number of subjects: 20
Study: 15717632

Group type: EXPERIMENTAL
Intervention: High-flux dialyzer
Number of subjects: 48

Group type: COMPARATOR
Intervention: Low-flux dialyzer
Number of subjects: 48
Study: 14522478

Group type: EXPERIMENTAL
Intervention: Clopidogrel pretreatment (300 mg before PCI)
Number of subjects: 4809
Study: 10233453

Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Intensive pelvic muscle exercises (PME)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: PME plus electrical stimulation (PME+ES)
Number of subjects: 63
Study: 8932971

Group type: EXPERIMENTAL
Intervention: Physicians' attitudes toward clinical trials
Number of subjects: 99
Study: 1918709

Group type: EXPERIMENTAL
Intervention: Balloon valvuloplasty
Number of subjects: 45

Group type: COMPARATOR
Intervention: Closed surgical valvotomy
Number of subjects: 45
Study: 6123017

Group type: EXPERIMENTAL
Intervention: Very-low protein diet (2.5% protein energy)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Dietary energy intake
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Energy intake
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 103
Study: 30772298

Group type: EXPERIMENTAL
Intervention: School-based intervention including increased access to school breakfast and student-directed marketing campaigns
Number of subjects: 387

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Intervention effect by end of school year
Number of subjects: 387
Study: 30134967

Group type: EXPERIMENTAL
Intervention: Atabecestat 10 mg
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Atabecestat 50 mg
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Atabecestat 10 mg and 50 mg
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Atabecestat (both doses)
Number of subjects: 63
Study: 27998899

Group type: EXPERIMENTAL
Intervention: Directed open‐glottis pushing
Number of subjects: 250

Group type: COMPARATOR
Intervention: Directed closed‐glottis pushing (Valsalva)
Number of subjects: 250
Study: 24813828

Group type: EXPERIMENTAL
Intervention: SOMNOwatch plus EEG
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: SOMNOwatch plus EEG (DOMINO Light)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Classical EEG amplifier (NeuroScan system)
Number of subjects: 13
Study: 22805313

Group type: EXPERIMENTAL
Intervention: Low-dose Korean red ginseng (3 g/day)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: High-dose Korean red ginseng (6 g/day)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: KRG supplementation (both doses)
Number of subjects: 57
Study: 19194969

Group type: EXPERIMENTAL
Intervention: Trans-resveratrol 25 mg, six times/day for thirteen doses
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Trans-resveratrol 50 mg, six times/day for thirteen doses
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Trans-resveratrol 100 mg, six times/day for thirteen doses
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Trans-resveratrol 150 mg, six times/day for thirteen doses
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 17447863

Group type: EXPERIMENTAL
Intervention: Tailored intervention group (received one tailored letter on all behaviors)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control intervention group (received one general information letter on all behaviors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tailored intervention group
Number of subjects: 0
Study: 15587571

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 11483803

Group type: EXPERIMENTAL
Intervention: Home visit intervention including an information package, discount coupons, and specific instruction regarding home safety measures.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nonintervention group (control).
Number of subjects: 100
Study: 9951927

Group type: EXPERIMENTAL
Intervention: Adjuvant locoregional chemoimmunotherapy (Gemcitabine 1 gm/m2, Carboplatin 200 mg/m2, Mitoxantrone 0.2 g/kg bw, IL-2, gamma-IFN)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Surgery alone (Control group)
Number of subjects: 512
Study: 7924365

Group type: EXPERIMENTAL
Intervention: Enterally fed patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nonenterally fed patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Medications containing glucose
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Blood glucose
Number of subjects: 30
Study: 3241259

Group type: EXPERIMENTAL
Intervention: Potassium supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1644987

Group type: EXPERIMENTAL
Intervention: Early partial sleep deprivation (PSD)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Late partial sleep deprivation (PSD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Total sleep time held constant (168 +/- 46 min in early sleep, 173 +/- 28 min in late sleep)
Number of subjects: 30
Study: 333603

Group type: EXPERIMENTAL
Intervention: Prophylactic cephalosporin
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 31582622

Group type: EXPERIMENTAL
Intervention: LDL-C lowering drug therapy (primarily statins)
Number of subjects: 104

Group type: COMPARATOR
Intervention: No LDL-C lowering drug therapy
Number of subjects: 104
Study: 31730454

Group type: EXPERIMENTAL
Intervention: Psychological morbidity assessment using the General Health Questionnaire (GHQ)-12
Number of subjects: 751

Group type: EXPERIMENTAL
Intervention: Factors associated with psychological morbidity
Number of subjects: 751
Study: 27875094

Group type: EXPERIMENTAL
Intervention: ERAS
Number of subjects: 149

Group type: COMPARATOR
Intervention: Conventional pathway
Number of subjects: 149
Study: 26094838

Group type: EXPERIMENTAL
Intervention: Clarithromycin 500mg with breakfast and lunch
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 22999292

Group type: EXPERIMENTAL
Intervention: Memantine plus risperidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus risperidone
Number of subjects: 0
Study: 21338973

Group type: EXPERIMENTAL
Intervention: PowerPoint presentation with illustrations on laparoscopic cholecystectomy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard explanation of surgical risks, complications, and benefits
Number of subjects: 50
Study: 19696138

Group type: EXPERIMENTAL
Intervention: Cerecyte coils
Number of subjects: 128

Group type: COMPARATOR
Intervention: Bare platinum coils
Number of subjects: 128
Study: 17373220

Group type: EXPERIMENTAL
Intervention: Grandio restorative system
Number of subjects: 40

Group type: COMPARATOR
Intervention: Transbond adhesive system
Number of subjects: 40
Study: 14648073

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1000 mg calcium carbonate for 6 weeks)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (no calcium supplementation)
Number of subjects: 27
Study: 11558809

Group type: EXPERIMENTAL
Intervention: Ocular compression (performed three times a day with a specific pattern of pressure application)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Cheekbone compression (control group, applied pressure to the zygomatic arch with the same frequency)
Number of subjects: 29
Study: 9645782

Group type: EXPERIMENTAL
Intervention: Unstructured case-based discussions
Number of subjects: 42

Group type: COMPARATOR
Intervention: Structured case-based discussions
Number of subjects: 42
Study: 7871090

Group type: COMPARATOR
Intervention: alpha-2 adrenoceptor antagonist (high dose)
Number of subjects: 12
Study: 3222146

Group type: EXPERIMENTAL
Intervention: (A, B, C) staging system
Number of subjects: 935

Group type: COMPARATOR
Intervention: Rai's staging system (stage 0)
Number of subjects: 935

Group type: EXPERIMENTAL
Intervention: Comparison of (A, B, C) staging system with Rai's staging system
Number of subjects: 935
Study: 31617447

Group type: EXPERIMENTAL
Intervention: Mastery Learning (ML)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Self-Directed Learning (SDL)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Online learning module (1 week prior) + Face-to-face component (45 minutes)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 145
Study: 28978818

Group type: EXPERIMENTAL
Intervention: G1-DES (First-Generation Drug-Eluting Stents)
Number of subjects: 4140

Group type: EXPERIMENTAL
Intervention: G2-DES (Second-Generation Drug-Eluting Stents)
Number of subjects: 4140
Study: 28386781

Group type: EXPERIMENTAL
Intervention: Auto-titrating continuous positive airway pressure (CPAP) for up to 1 year
Number of subjects: 225

Group type: COMPARATOR
Intervention: Usual care and unattended polysomnography at the end of the study
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Auto-titrating CPAP
Number of subjects: 225
Study: 24858488

Group type: EXPERIMENTAL
Intervention: CON-CT
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: HI-CT
Number of subjects: 72

Group type: COMPARATOR
Intervention: RT-only
Number of subjects: 72

Group type: COMPARATOR
Intervention: HC
Number of subjects: 72
Study: 23539235

Group type: EXPERIMENTAL
Intervention: BIS-guided anaesthesia
Number of subjects: 1155

Group type: COMPARATOR
Intervention: Blinded BIS monitoring (control)
Number of subjects: 1155

Group type: EXPERIMENTAL
Intervention: BIS monitoring
Number of subjects: 1155
Study: 22130747

Group type: EXPERIMENTAL
Intervention: Collaborative stepped care intervention led by lay health counsellors
Number of subjects: 2796

Group type: COMPARATOR
Intervention: Enhanced usual care (control group)
Number of subjects: 2796
Study: 19320897

Group type: EXPERIMENTAL
Intervention: Negative pressure instillation therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard surgical debridement with gentamicin polymethylmethacrylate beads and long‐term intravenous antibiotics (Control)
Number of subjects: 30
Study: 17081208

Group type: EXPERIMENTAL
Intervention: Atrial-based dual-chamber managed ventricular pacing mode (MVP™)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: VVI 40 pacing
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: MVP™
Number of subjects: 1000

Group type: COMPARATOR
Intervention: VVI 40
Number of subjects: 1000
Study: 15144943

Group type: EXPERIMENTAL
Intervention: Initiation of carvedilol before discharge
Number of subjects: 363

Group type: COMPARATOR
Intervention: Usual care (waiting 2 to 4 weeks after hospitalization)
Number of subjects: 363
Study: 10813543

Group type: EXPERIMENTAL
Intervention: Mobilization with cyclophosphamide (CY) plus G-CSF
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Mobilization with CY plus GM-CSF
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Mobilization with CY plus GM-CSF (8 days) followed by G-CSF
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Poor mobilization (failed to mobilize >0.4 x 10(6) CD34+ cells/kg)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Good mobilizers in MM (n=24)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Non-mobilizers in MM (n=5)
Number of subjects: 57
Study: 8925804

Group type: COMPARATOR
Intervention: High-protein meal (80 gm total protein: 4.1 g phenylalanine, 8.2 g leucine, 4.2 g isoleucine, 52 g carbohydrate, 9 g fat)
Number of subjects: 10

Group type: COMPARATOR
Intervention: High-protein meal
Number of subjects: 10
Study: 1516877

Group type: EXPERIMENTAL
Intervention: Remefa S (glycyrrhizinic acid), administered three times a week for 12 months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Interferon (comparison suggested)
Number of subjects: 10
Study: 6148361

Group type: EXPERIMENTAL
Intervention: ranitidine (300 mg/day)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: cimetidine (1200 mg/day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: nothing (control)
Number of subjects: 11
Study: 30396629

Group type: EXPERIMENTAL
Intervention: Wheelchair Tai Chi (WCTC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (normal rehabilitation intervention)
Number of subjects: 40
Study: 28407661

Group type: EXPERIMENTAL
Intervention: Saxagliptin 5 mg per day for 12 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Metformin 1,500 mg per day for 12 weeks
Number of subjects: 31
Study: 25806893

Group type: EXPERIMENTAL
Intervention: Caring for the Caregiver Programme (CCP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 80
Study: 23261025

Group type: EXPERIMENTAL
Intervention: Triclosan-coated polyglactin 910 antimicrobial sutures
Number of subjects: 410

Group type: COMPARATOR
Intervention: Conventional wound closures with polyglactin 910 sutures
Number of subjects: 410
Study: 19349077

Group type: EXPERIMENTAL
Intervention: Short DUE (≤8 weeks)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Long DUE (>8 weeks)
Number of subjects: 141
Study: 18316567

Group type: EXPERIMENTAL
Intervention: IFN‐α‐2b at 5 megaunits/m2
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: IFN‐α‐2b at 10 megaunits/m2
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: IFN‐α‐2b at 5 megaunits/m2 and 10 megaunits/m2
Number of subjects: 11
Study: 16025958

Group type: EXPERIMENTAL
Intervention: Compound Duzhong Jiangu granule (CDJG)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Zhuanggu Guanjie pill (ZGP)
Number of subjects: 600
Study: 14504154

Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA) with bupivacaine (0.25% during operation, 0.125% after operation) and fentanyl (2 microg ml(‐1))
Number of subjects: 38

Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA)
Number of subjects: 38
Study: 9933260

Group type: EXPERIMENTAL
Intervention: Medically treated patients with IAD and extracranial ICA stenosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgically treated patients with IAD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CE) in patients with IAD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CE) in patients without IAD
Number of subjects: 0
Study: 7749445

Group type: EXPERIMENTAL
Intervention: Continuous lateral rotation therapy
Number of subjects: 69

Group type: COMPARATOR
Intervention: Stationary bed
Number of subjects: 69
Study: 2405324

Group type: EXPERIMENTAL
Intervention: Pipelle
Number of subjects: 156

Group type: COMPARATOR
Intervention: Tis‐u‐trap
Number of subjects: 156
Study: 7018048

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31977627

Group type: EXPERIMENTAL
Intervention: Neostigmine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sugammadex
Number of subjects: 80
Study: 31608608

Group type: EXPERIMENTAL
Intervention: Postoperative antibiotics prescribed for 44% of the extractions
Number of subjects: 992

Group type: COMPARATOR
Intervention: No postoperative antibiotics prescribed
Number of subjects: 992
Study: 27846058

Group type: EXPERIMENTAL
Intervention: Investigational hexavalent vaccine (HV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pentacel (Control)
Number of subjects: 0
Study: 26018388

Group type: EXPERIMENTAL
Intervention: ImmunoCard STAT!® CGE test
Number of subjects: 0

Group type: COMPARATOR
Intervention: rt‐PCR for the detection of E. histolytica / E. dispar DNA
Number of subjects: 0
Study: 23603234

Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl + 17% EDTA
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl + 7% maleic acid
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Distilled water
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: QMix
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Maleic acid
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: EDTA
Number of subjects: 50
Study: 21565796

Group type: EXPERIMENTAL
Intervention: D/E + fenofibrate + niacin
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: D/E + fenofibrate
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: D/E + niacin
Number of subjects: 191

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 191
Study: 19765505

Group type: EXPERIMENTAL
Intervention: Active telephone recruitment into quitline support
Number of subjects: 1562

Group type: EXPERIMENTAL
Intervention: Active telephone recruitment
Number of subjects: 1562

Group type: COMPARATOR
Intervention: Participants compared to NSW adult daily smokers
Number of subjects: 1562
Study: 17577495

Group type: EXPERIMENTAL
Intervention: Tramadol preoperative, 100 mg IM 1 hour before surgery (group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tramadol postoperative, 100 mg IM immediately after surgery (group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (group C)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tramadol preoperative (group A)
Number of subjects: 60
Study: 15143712

Group type: EXPERIMENTAL
Intervention: Nuzhen Yunyu Decoction (NYD)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Clomiphene citrate (Control)
Number of subjects: 68
Study: 11740320

Group type: EXPERIMENTAL
Intervention: RRV-tetravalent vaccine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 9973803

Group type: EXPERIMENTAL
Intervention: Oxatomide (1 mg/kg/day) in one evening dose
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Oxatomide (1 mg/kg/day) divided into two administrations
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Oxatomide (2 mg/kg/day) after dosage increase
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 8737757

Group type: EXPERIMENTAL
Intervention: (S)-propafenone hydrochloride
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: (R)-propafenone hydrochloride
Number of subjects: 12
Study: 2328183

Group type: EXPERIMENTAL
Intervention: Halothane in concentrations exceeding 1.2 mmol litre‐1
Number of subjects: 12
Study: 6116610

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Acebutolol 400 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 29445912

Group type: EXPERIMENTAL
Intervention: Pan-fried beef steak (270±20 g)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sous-vide beef steak (270±20 g)
Number of subjects: 12
Study: 28814143

Group type: EXPERIMENTAL
Intervention: LY3045697
Number of subjects: 51

Group type: COMPARATOR
Intervention: Spironolactone 25 mg/d
Number of subjects: 51
Study: 25810334

Group type: EXPERIMENTAL
Intervention: Patients without AF
Number of subjects: 6054

Group type: COMPARATOR
Intervention: Patients with AF
Number of subjects: 6054

Group type: EXPERIMENTAL
Intervention: Independent predictors of stroke in patients without AF
Number of subjects: 6054